Facilitated By

San Antonio Medical Foundation

A A PHASE 2 PROOF OF CONCEPT, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY OF ASP1128 (MA-0217) IN SUBJECTS AT RISK FOR ACUTE KIDNEY INJURY FOLLOWING CORONARY ARTERY BYPASS GRAFT (CABG) AND/OR VALVE SURGERY

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Hui, Dawn S
Funded by
ASTELLAS PHARMA
Research Start Date
Status
Active
Collaborative Project
Clinical Care
Drug Discovery
Cardiovascular